North America Flow Cytometry Market Size & Outlook
North America flow cytometry market, 2018-2030 (US$M)
Related Markets
North America flow cytometry market highlights
- The North America flow cytometry market generated a revenue of USD 1,779.2 million in 2023.
- The market is expected to grow at a CAGR of 7.2% from 2024 to 2030.
- In terms of segment, instruments was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 1,779.2 million |
| Market revenue in 2030 | USD 2,902.1 million |
| Growth rate | 7.2% (CAGR from 2023 to 2030) |
| Largest segment | Instruments |
| Fastest growing segment | Software |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & Consumables, Software, Accessories, Services |
| Key market players worldwide | Danaher Corp, BD, Sysmex Corp, Agilent Technologies, Apogee Enterprises Inc, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Wipro Ltd ADR, Diasorin SpA, Miltenyi Biotec, Sony Group Corp |
Other key industry trends
- In terms of revenue, North America region accounted for 41.2% of the global flow cytometry market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,656.6 million by 2030.
Instruments was the largest segment with a revenue share of 35.12% in 2023. Horizon Databook has segmented the North America flow cytometry market based on instruments, reagents & consumables, software, accessories, services covering the revenue growth of each sub-segment from 2018 to 2030.
In 2021, North America held a substantial share of the global flow cytometry market. This large share can be attributed to the presence of well-established healthcare system and pharmaceutical industry in the U.S., which has created a significant demand for flow cytometry solutions for clinical and research purposes.
Extensive R&D initiatives being undertaken for developing vaccines & therapeutics for COVID-19 and increasing public-private investments in the field of cancer research have also fueled the need for flow cytometry solutions in the country, thus leading to high market growth.
In addition, continuous advancements in the field of flow cytometry and high affordability & adoption of innovative and advanced flow cytometry systems & solutions in the U.S. make it the most lucrative market in the world.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Flow Cytometry Market Scope
Flow Cytometry Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America flow cytometry market size, by country, 2018-2030 (US$M)
North America Flow Cytometry Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
